Skip to main content
. 2021 Mar 9;10(6):e019854. doi: 10.1161/JAHA.120.019854

Figure 2. Thirty‐day mortality following reoperative mitral valve replacement (MVR) for bioprosthetic mitral structural valve degeneration (SVD).

Figure 2

Shown here are the 30‐day mortality rates, in ascending chronological order of year of publication, following redo‐MVR for bioprosthetic mitral SVD among various surgical series. The error bars indicate the 95% CIs. 7 , 8 , 14 , 17 , 18 , 20 , 22 , 23